The global oxycodone drugs market is projected to expand from USD 7.06 billion in 2025 to approximately USD 11.53 billion by 2034, growing at a CAGR of 5.61%. North America led the market in 2024, driven by a high prevalence of chronic pain conditions and aging demographics. The market benefits from increasing approvals of abuse-deterrent formulations and continued demand for opioid-based pain relief.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Oxycodone Drugs Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Oxycodone Drugs Market Revenue and Volume, by Product Type
8.1.1 Short-acting
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Long acting
8.1.2.1. Market Revenue and Volume Forecast
9.1. Oxycodone Drugs Market Revenue and Volume, by Distribution Channel
9.1.1. Hospital Pharmacies
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Retail Pharmacies
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Online Pharmacies
9.1.3.1. Market Revenue and Volume Forecast
10.1. Oxycodone Drugs Market Revenue and Volume, by March
10.1.1. Consumer
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Automotive
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Industrial
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Cheese
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Others
10.1.5.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Product Type
11.1.2. Market Revenue and Volume Forecast, by Distribution Channel
11.1.3. Market Revenue and Volume Forecast, by March
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Product Type
11.1.4.2. Market Revenue and Volume Forecast, by Distribution Channel
11.1.4.3. Market Revenue and Volume Forecast, by March
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Product Type
11.1.5.2. Market Revenue and Volume Forecast, by Distribution Channel
11.1.5.3. Market Revenue and Volume Forecast, by March
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Product Type
11.2.2. Market Revenue and Volume Forecast, by Distribution Channel
11.2.3. Market Revenue and Volume Forecast, by March
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Product Type
11.2.4.2. Market Revenue and Volume Forecast, by Distribution Channel
11.2.4.3. Market Revenue and Volume Forecast, by March
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Product Type
11.2.5.2. Market Revenue and Volume Forecast, by Distribution Channel
11.2.5.3. Market Revenue and Volume Forecast, by March
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Product Type
11.2.6.2. Market Revenue and Volume Forecast, by Distribution Channel
11.2.6.3. Market Revenue and Volume Forecast, by March
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Product Type
11.2.7.2. Market Revenue and Volume Forecast, by Distribution Channel
11.2.7.3. Market Revenue and Volume Forecast, by March
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Product Type
11.3.2. Market Revenue and Volume Forecast, by Distribution Channel
11.3.3. Market Revenue and Volume Forecast, by March
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Product Type
11.3.4.2. Market Revenue and Volume Forecast, by Distribution Channel
11.3.4.3. Market Revenue and Volume Forecast, by March
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Product Type
11.3.5.2. Market Revenue and Volume Forecast, by Distribution Channel
11.3.5.3. Market Revenue and Volume Forecast, by March
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Product Type
11.3.6.2. Market Revenue and Volume Forecast, by Distribution Channel
11.3.6.3. Market Revenue and Volume Forecast, by March
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Product Type
11.3.7.2. Market Revenue and Volume Forecast, by Distribution Channel
11.3.7.3. Market Revenue and Volume Forecast, by March
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Product Type
11.4.2. Market Revenue and Volume Forecast, by Distribution Channel
11.4.3. Market Revenue and Volume Forecast, by March
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Product Type
11.4.4.2. Market Revenue and Volume Forecast, by Distribution Channel
11.4.4.3. Market Revenue and Volume Forecast, by March
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Product Type
11.4.5.2. Market Revenue and Volume Forecast, by Distribution Channel
11.4.5.3. Market Revenue and Volume Forecast, by March
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Product Type
11.4.6.2. Market Revenue and Volume Forecast, by Distribution Channel
11.4.6.3. Market Revenue and Volume Forecast, by March
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Product Type
11.4.7.2. Market Revenue and Volume Forecast, by Distribution Channel
11.4.7.3. Market Revenue and Volume Forecast, by March
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Product Type
11.5.2. Market Revenue and Volume Forecast, by Distribution Channel
11.5.3. Market Revenue and Volume Forecast, by March
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Product Type
11.5.4.2. Market Revenue and Volume Forecast, by Distribution Channel
11.5.4.3. Market Revenue and Volume Forecast, by March
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Product Type
11.5.5.2. Market Revenue and Volume Forecast, by Distribution Channel
11.5.5.3. Market Revenue and Volume Forecast, by March
12.1. Teva Pharmaceutical Industries Ltd
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Endo Pharmaceuticals Inc
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Collegium Pharmaceutical Inc
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Mallinckrodt Pharmaceuticals
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Sun Pharmaceutical Industries Ltd
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description